Experimental Pathology Laboratory (EPL)

$1,018,655ZICFY2023CANIH

Division Of Basic Sciences - Nci

Investigators

Linked publications & trials

Paper 38918394 Paper 38912586 Paper 38897168 Paper 38709562 Paper 38398178 Paper 38230434 Paper 37725716 Paper 37224815 Paper 37205196 Paper 37169743 Paper 37090576 Paper 37090574 Paper 37031249 Paper 36963628 Paper 36932076 Paper 36869703 Paper 36790955 Paper 36754451 Paper 36715552 Paper 36695611 Paper 35816430 Paper 35699495 Paper 35383277 Paper 35351966 Paper 35262093 Paper 35034369 Paper 34811556 Paper 34255745 Paper 34253580 Paper 34195677 Paper 34071938 Paper 33851061 Paper 33834359 Paper 33767405 Paper 33536203 Paper 33526872 Paper 33481911 Paper 33129371 Paper 33103210 Paper 32936035 Paper 32835732 Paper 32762616 Paper 32637350 Paper 32502310 Paper 32483558 Paper 32367248 Paper 32316112 Paper 32107047 Paper 32068253 Paper 31949145 Paper 31911546 Paper 31864026 Paper 31527799 Paper 29956066 Paper 29925955 Paper 29700408 Paper 29548022 Paper 29492969 Paper 29472714 Paper 29457738 Paper 29443622 Paper 29437706 Paper 29307568 Paper 29125916 Paper 29024776 Paper 28347266 Paper 28339906 Paper 27548802 Paper 27221702 Paper 27177816 Paper 27154171 Paper 26337566 Paper 26044002 Paper 26043998 Paper 26022333 Paper 25870121 Paper 25838812 Paper 25774315 Paper 25763314 Paper 25636426 Paper 25023613 Paper 24883046 Paper 24809843 Paper 24487999

Abstract

Long-term research efforts in the EPL, in support of translational pathology include: developments of new hardware for the construction of tissue microarrays, the development of a tissue microarray instrument for frozen tissue, refinement of technologies for tissue micro-dissection. Additional efforts in the EPL focus on tissue preservation and storage, with efforts in the development of non-formaldehyde containing tissue fixatives, refinement to tissue impregnation systems to prevent tissue degradation and development of methods for freezing and storing tissue that prevent degradation. We filed invention reports in this fiscal year, both of which will be filed as preliminary patent applications. The research we support involves numerous types of cancers and other diseases, including COVID-19.

View original record on NIH RePORTER →